OTC •
Healthcare •
Biotechnology •
Quote as of 08/24/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization8.98 mln
Earnings Date08/14/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-28.21
Highly reliable
Relative Strength
100
/ 100
Top performer
Debt / Equity
-0.13
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Aditxt Inc. is a California-based company focused on developing tools and treatments that help people better understand and manage their immune systems. Its core offerings include a personal immune health monitoring system and a therapy designed to teach the body to tolerate its own tissues, reducing harmful immune responses. The company is also advancing treatments for conditions such as psoriasis, type 1 diabetes, and multiple sclerosis, supported by licensing agreements with two leading research universities.
